REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 428 filers reported holding REPLIGEN CORP in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,615 | -84.4% | 551 | -86.1% | 0.00% | -100.0% |
| Q2 2023 | $560,747 | +177.6% | 3,964 | +230.3% | 0.00% | +100.0% |
| Q1 2023 | $202,032 | -84.9% | 1,200 | -83.3% | 0.00% | -87.5% |
| Q3 2022 | $1,342,000 | -63.5% | 7,170 | -63.3% | 0.01% | -74.2% |
| Q1 2022 | $3,675,000 | -54.1% | 19,538 | -35.3% | 0.03% | -50.0% |
| Q4 2021 | $8,000,000 | +73.1% | 30,208 | +88.9% | 0.06% | +6.9% |
| Q3 2021 | $4,622,000 | -21.2% | 15,995 | -45.6% | 0.06% | -13.4% |
| Q2 2021 | $5,869,000 | +199.6% | 29,403 | +187.6% | 0.07% | +139.3% |
| Q4 2020 | $1,959,000 | -57.9% | 10,222 | -67.6% | 0.03% | -57.6% |
| Q3 2020 | $4,650,000 | +13.5% | 31,516 | -4.9% | 0.07% | +10.0% |
| Q2 2020 | $4,096,000 | – | 33,135 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |